Search clinical trials for: GW427353

Total 3 results

GlaxoSmithKline

Completed

A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS)

Germany, Australia, France
GlaxoSmithKline

Completed

A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers

Irritable Bowel Syndrome (IBS)

United States
GlaxoSmithKline

Completed

A Two-Part Study to Determine: Best Medication Formulation and Food Effect

Overactive Bladder

United States

3

Subscribe